These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
431 related items for PubMed ID: 19786093
1. Role of the extracellular amino terminus and first membrane-spanning helix of dopamine D1 and D5 receptors in shaping ligand selectivity and efficacy. D'Aoust JP, Tiberi M. Cell Signal; 2010 Jan; 22(1):106-16. PubMed ID: 19786093 [Abstract] [Full Text] [Related]
2. The third intracellular loop of D1 and D5 dopaminergic receptors dictates their subtype-specific PKC-induced sensitization and desensitization in a receptor conformation-dependent manner. Plouffe B, Yang X, Tiberi M. Cell Signal; 2012 Jan; 24(1):106-18. PubMed ID: 21893192 [Abstract] [Full Text] [Related]
3. Probing the constitutive activity among dopamine D1 and D5 receptors and their mutants. Plouffe B, D'Aoust JP, Laquerre V, Liang B, Tiberi M. Methods Enzymol; 2010 Jan; 484():295-328. PubMed ID: 21036239 [Abstract] [Full Text] [Related]
4. Functional analysis of human D1 and D5 dopaminergic G protein-coupled receptors: lessons from mutagenesis of a conserved serine residue in the cytosolic end of transmembrane region 6. Plouffe B, Tiberi M. Methods Mol Biol; 2013 Jan; 964():141-80. PubMed ID: 23296783 [Abstract] [Full Text] [Related]
5. Functional importance of two conserved residues in intracellular loop 1 and transmembrane region 2 of Family A GPCRs: insights from ligand binding and signal transduction responses of D1 and D5 dopaminergic receptor mutants. Zhang B, Yang X, Tiberi M. Cell Signal; 2015 Oct; 27(10):2014-25. PubMed ID: 26186971 [Abstract] [Full Text] [Related]
6. Identification of human dopamine D1-like receptor agonist using a cell-based functional assay. Jiang N, Ou-Yang KQ, Cai SX, Hu YH, Xu ZL. Acta Pharmacol Sin; 2005 Oct; 26(10):1181-6. PubMed ID: 16174433 [Abstract] [Full Text] [Related]
7. Spare receptors and intrinsic activity: studies with D1 dopamine receptor agonists. Watts VJ, Lawler CP, Gonzales AJ, Zhou QY, Civelli O, Nichols DE, Mailman RB. Synapse; 1995 Oct; 21(2):177-87. PubMed ID: 8584979 [Abstract] [Full Text] [Related]
8. Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1. Sunahara RK, Guan HC, O'Dowd BF, Seeman P, Laurier LG, Ng G, George SR, Torchia J, Van Tol HH, Niznik HB. Nature; 1991 Apr 18; 350(6319):614-9. PubMed ID: 1826762 [Abstract] [Full Text] [Related]
9. Conformational analysis of D1 dopamine receptor agonists: pharmacophore assessment and receptor mapping. Mottola DM, Laiter S, Watts VJ, Tropsha A, Wyrick SD, Nichols DE, Mailman RB. J Med Chem; 1996 Jan 05; 39(1):285-96. PubMed ID: 8568818 [Abstract] [Full Text] [Related]
10. Functional analysis of the human D5 dopamine receptor missense and nonsense variants: differences in dopamine binding affinities. Cravchik A, Gejman PV. Pharmacogenetics; 1999 Apr 05; 9(2):199-206. PubMed ID: 10376767 [Abstract] [Full Text] [Related]
11. Direct protein-protein coupling enables cross-talk between dopamine D5 and gamma-aminobutyric acid A receptors. Liu F, Wan Q, Pristupa ZB, Yu XM, Wang YT, Niznik HB. Nature; 2000 Jan 20; 403(6767):274-80. PubMed ID: 10659839 [Abstract] [Full Text] [Related]
12. Dopamine D1 and D5 receptors differentially regulate oxidative stress through paraoxonase 2 in kidney cells. Yang S, Yang Y, Yu P, Yang J, Jiang X, Villar VA, Sibley DR, Jose PA, Zeng C. Free Radic Res; 2015 Apr 20; 49(4):397-410. PubMed ID: 25740199 [Abstract] [Full Text] [Related]
13. Role of the fourth intracellular loop of D1-like dopaminergic receptors in conferring subtype-specific signaling properties. Tumova K, Zhang D, Tiberi M. FEBS Lett; 2004 Oct 22; 576(3):461-7. PubMed ID: 15498581 [Abstract] [Full Text] [Related]
14. Mutagenesis of residues adjacent to transmembrane prolines alters D1 dopamine receptor binding and signal transduction. Cho W, Taylor LP, Akil H. Mol Pharmacol; 1996 Nov 22; 50(5):1338-45. PubMed ID: 8913366 [Abstract] [Full Text] [Related]
15. Dopamine D5 receptor agonist high affinity and constitutive activity profile conferred by carboxyl-terminal tail sequence. Demchyshyn LL, McConkey F, Niznik HB. J Biol Chem; 2000 Aug 04; 275(31):23446-55. PubMed ID: 10807903 [Abstract] [Full Text] [Related]
16. Identification of human dopamine receptors agonists from Chinese herbs. Zhang YL, Zhang HQ, Liu XY, Hua SN, Zhou LB, Yu J, Tan XH. Acta Pharmacol Sin; 2007 Jan 04; 28(1):132-9. PubMed ID: 17184593 [Abstract] [Full Text] [Related]
18. Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists. Ryman-Rasmussen JP, Nichols DE, Mailman RB. Mol Pharmacol; 2005 Oct 04; 68(4):1039-48. PubMed ID: 15985612 [Abstract] [Full Text] [Related]
19. Structural determinants of pharmacological specificity between D(1) and D(2) dopamine receptors. Lan H, Durand CJ, Teeter MM, Neve KA. Mol Pharmacol; 2006 Jan 04; 69(1):185-94. PubMed ID: 16236817 [Abstract] [Full Text] [Related]
20. Dopamine/serotonin receptor ligands. 10: SAR Studies on azecine-type dopamine receptor ligands by functional screening at human cloned D1, D2L, and D5 receptors with a microplate reader based calcium assay lead to a novel potent D1/D5 selective antagonist. Hoefgen B, Decker M, Mohr P, Schramm AM, Rostom SA, El-Subbagh H, Schweikert PM, Rudolf DR, Kassack MU, Lehmann J. J Med Chem; 2006 Jan 26; 49(2):760-9. PubMed ID: 16420061 [Abstract] [Full Text] [Related] Page: [Next] [New Search]